Therefore, an evaluation of literature regarding the regulation of CDK4/6 in gastric cancer is also necessary in order to understand the field of small molecule inhibitors and the ways in which gastric cancer cells may overcome the drug effects using alternative mechanisms of the regulation of these players. The gene discussed is CDK4; the disease is gastric cancer.